1. Home
  2. CNTN vs PIM Comparison

CNTN vs PIM Comparison

Compare CNTN & PIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canton Strategic Holdings Inc. Common Stock

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$2.69

Market Cap

178.5M

Sector

Health Care

ML Signal

N/A

Logo Putnam Master Intermediate Income Trust

PIM

Putnam Master Intermediate Income Trust

N/A

Current Price

$3.01

Market Cap

153.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CNTN
PIM
Founded
2017
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
178.5M
153.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
CNTN
PIM
Price
$2.69
$3.01
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 644.3K
67.3K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
★ 8.28%
EPS Growth
★ 88.10
N/A
EPS
N/A
★ 0.05
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$60.40
Revenue Growth
N/A
N/A
52 Week Low
$1.75
$2.98
52 Week High
$5.27
$3.46

Technical Indicators

Market Signals
Indicator
CNTN
PIM
Relative Strength Index (RSI) 68.25 35.43
Support Level $2.09 $2.98
Resistance Level $3.01 $3.21
Average True Range (ATR) 0.17 0.05
MACD 0.05 -0.01
Stochastic Oscillator 100.00 13.16

Price Performance

Historical Comparison
CNTN
PIM

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company operates in two reportable segments: digital asset treasury and clinical stage bio-technology. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

About PIM Putnam Master Intermediate Income Trust

Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.

Share on Social Networks: